Васкулогенная мимикрия

Закрыть метаданные

Рекомендуем статьи по данной теме:

Патолого-анатомический алгоритм дифференциальной диагностики болезни Педжета молочной железы. Архив патологии. 2023;(2):32-39

Варианты коллатерального кровообращения головного мозга при болезни моя-моя. Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко. 2023;(3):20-28

Факторы эффективности неоваскуляризации после хирургического лечения болезни моя-моя. Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко. 2023;(3):29-39

Подбор модели нейронной сети для раннего обнаружения меланомы кожи. Клиническая дерматология и венерология. 2023;(3):287-295

Роль микроРНК в патогенезе заболеваний, связанных с нарушением функции слезной железы. Вестник офтальмологии. 2023;(3):112-118

Роль микроРНК в норме и при патологии эндометрия. Российский вестник акушера-гинеколога. 2023;(4):27-34

Использование чат-ботов с применением искусственного интеллекта как элемента обучения при работе с дерматоскопическими изображениями. Клиническая дерматология и венерология. 2023;(4):447-453

Рассеянный склероз и меланома. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;(10):123-128

Применение антиангиогенных препаратов является одним из направлений терапии злокачественных новообразований. Установлено, что развитие феномена васкулогенной мимикрии — специфичного варианта опухолевого неоангиогенеза, формирующегося в высокоагрессивных солидных опухолях, связано со снижением эффективности противоопухолевой терапии. В настоящем обзоре освещены механизмы развития васкулогенной мимикрии при злокачественных новообразованиях, являющейся одним из альтернативных вариантов кровоснабжения опухоли. В формировании васкулогенной мимикрии немаловажная роль отводится опухолевому микроокружению, в первую очередь опухолеассоциированным макрофагам и фибробластам. Охарактеризованы сигнальные пути, регулирующие образование каналов васкулогенной мимикрии в опухолях. Показаны перспективы целенаправленного воздействия на молекулярные мишени, инициирующие и способствующие васкулогенной мимикрии, воздействие на которые может повысить эффективность противоопухолевой терапии. В обзоре обсуждены экспериментальные исследования механизмов формирования васкулогенной мимикрии при злокачественных новообразованиях и перспективы таргетного воздействия на молекулярные мишени — компоненты сигнальных каскадов, участвующих в развитии данной модели неоангиогенеза.

Ключевые слова:

васкулогенная мимикрия

неоангиогенез

меланома

сигнальные пути

микроРНК

Авторы:

Лапкина Е.З.

Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого

ORCID: 0000-0002-7226-9565

Есимбекова А.Р.

Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого

ORCID: 0000-0001-6363-5941

Рукша Т.Г.

ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Минздрава России

ORCID: 0000-0001-8142-4283

Дата поступления:

05.06.2023

Дата принятия в печать:

12.09.2023

Список литературы:

Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW. Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol Ther. 2016;159:83-92. https://doi.org/10.1016/j.pharmthera.2016.01.006
Andreucci E, Peppicelli S, Ruzzolini J, Bianchini F, Calorini L. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. Cancer Metastasis Rev. 2022;41(4):935-951. https://doi.org/10.1007/s10555-022-10067-x
Krishna Priya S, Nagare RP, Sneha VS, Sidhanth C, Bindhya S, Manasa P, Ganesan TS. Tumour angiogenesis-origin of blood vessels. Int J Cancer. 2016;139(4):729-735. https://doi.org/10.1002/ijc.30067
Harry JA, Ormiston ML. Novel pathways for targeting tumor angiogenesis in metastatic breast cancer. Front Oncol. 2021;11:772305. https://doi.org/10.3389/fonc.2021.772305
Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nat Rev Clin Oncol. 2019;16(8):469-493. https://doi.org/10.1038/s41571-019-0181-9
Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, Trent JM, Meltzer PS, Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739-752.
Treps L, Faure S, Clere N. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis — interest in making it a therapeutic target. Pharmacol Ther. 2021;223:107805. https://doi.org/10.1016/j.pharmthera.2021.107805
Valdivia A, Mingo G, Aldana V, Pinto MP, Ramirez M, Retamal C, Gonzalez A, Nualart F, Corvalan AH, Owen GI. Fact or fiction, it is time for a verdict on vasculogenic mimicry? Front Oncol. 2019;9:680. https://doi.org/10.3389/fonc.2019.00680
Stålhammar G, See TRO, Phillips SS, Grossniklaus HE. Density of PAS positive patterns in uveal melanoma: correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis. Mol Vis. 2019;25:502-516.
Liu Q, Qiao L, Liang N, Xie J, Zhang J, Deng G, Luo H, Zhang J. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med. 2016;20(9):1761-1769. https://doi.org/10.1111/jcmm.12851
Kim H, Lee S, Shin E, Seong KM, Jin YW, Youn H, Youn B. The emerging roles of exosomes as EMT regulators in cancer. Cells. 2020;9(4):861. https://doi.org/10.3390/cells9040861
Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10-24. https://doi.org/10.1016/j.semcancer.2017.02.011
Zhang D, Sun B, Zhao X, Sun H, An J, Lin X, Zhu D, Zhao X, Wang X, Liu F, et al. Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer. J Cell Mol Med. 2020;24(13):7163-7174. https://doi.org/10.1111/jcmm.15167
Vishnubalaji R, Manikandan M, Fahad M, Hamam R, Alfayez M, Kassem M, Aldahmash A, Alajez NM. Molecular profiling of ALDH1+ colorectal cancer stem cells reveals preferential activation of MAPK, FAK, and oxidative stress pro-survival signalling pathways. Oncotarget. 2018;9(17):13551-13564. https://doi.org/10.18632/oncotarget.24420
Sun H, Yao N, Cheng S, Li L, Liu S, Yang Z, Shang G, Zhang D, Yao Z. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer. Cancer Biol Med. 2019;16(2):299-311. https://doi.org/10.20892/j.issn.2095-3941.2018.0209
Cavaco A, Rezaei M, Niland S, Eble JA. Collateral damage intended-cancer-associated fibroblasts and vasculature are potential targets in cancer therapy. Int J Mol Sci. 2017;18(11):2355. https://doi.org/10.3390/ijms18112355
Yang J, Lu Y, Lin YY, Zheng ZY, Fang JH, He S, Zhuang SM. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. Cancer Lett. 2016;383(1):18-27. https://doi.org/10.1016/j.canlet.2016.09.012
Pan MS, Wang H, Ansari KH, Li XP, Sun W, Fan YZ. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway. J Exp Clin Cancer Res. 2020;39(1):234. https://doi.org/10.1186/s13046-020-01742-4
Shi L, Lei D, Ma C, Xu F, Li Y, Wang Y, Cong N, Liu D, Pan XL. Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma. J Int Med Res. 2010;38(4):1276-1286. https://doi.org/10.1177/147323001003800409
Tsai YM, Wu KL, Liu YW, Chang WA, Huang YC, Chang CY, Tsai PH, Liao SH, Hung JY, Hsu YL. Cooperation between cancer and fibroblasts in vascular mimicry and N2-type neutrophil recruitment via Notch2-Jagged1 interaction in lung cancer. Front Oncol. 2021;11:696931. https://doi.org/10.3389/fonc.2021.696931
Barricklow Z, DiVincenzo MJ, Angell CD, Carson WE. Ulcerated cutaneous melanoma: a review of the clinical, histologic, and molecular features associated with a clinically aggressive histologic phenotype. Clin Cosmet Investig Dermatol. 2022;15:1743-1757. https://doi.org/10.2147/CCID.S372287
Tan LY, Cockshell MP, Moore E, Myo Min KK, Ortiz M, Johan MZ, Ebert B, Ruszkiewicz A, Brown MP, Ebert LM, et al. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. Oncoimmunology. 2022;11(1):2043673. https://doi.org/10.1080/2162402X.2022.2043673
Rong X, Huang B, Qiu S, Li X, He L, Peng Y. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. Oncotarget. 2016;7(51):83976-83986. https://doi.org/10.18632/oncotarget.6930
Liu Q, Zhao E, Geng B, Gao S, Yu H, He X, Li X, Dong G, You B. Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry. Cell Death Dis. 2022;13(4):382. https://doi.org/10.1038/s41419-022-04814-9
Zhang L, Xu Y, Sun J, Chen W, Zhao L, Ma C, Wang Q, Sun J, Huang B, Zhang Y, et al. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells. Oncotarget. 2017;8(1):819-832. https://doi.org/10.18632/oncotarget.13661
Zhang L, Xu Y, Sun J, Chen W, Zhao L, Ma C, Wang Q, Sun J, Huang B, Zhang Y, et al. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells. Oncotarget. 2017;8(1):819-832. https://doi.org/10.18632/oncotarget.13661
Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, Hendrix MJ. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol. 2012;181(4):1115-1125. https://doi.org/10.1016/j.ajpath.2012.07.013
Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther. 2006;5(2):228-233. https://doi.org/10.4161/cbt.5.2.2510
Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003;63(16):4757-4762.
Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437(2):169-183. https://doi.org/10.1042/BJ20110301
Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Res. 2006;66(21): 10315-10324. https://doi.org/10.1158/0008-5472.CAN-06-1560
Vartanian A, Stepanova E, Grigorieva I, Solomko E, Baryshnikov A, Lichinitser M. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner. Melanoma Res. 2011;21(2):91-98. https://doi.org/10.1097/CMR.0b013e328343a237
Xu X, Zong Y, Gao Y, Sun X, Zhao H, Luo W, Jia S. VEGF induce vasculogenic mimicry of choroidal melanoma through the PI3k signal pathway. Biomed Res Int. 2019;2019:3909102. https://doi.org/10.1155/2019/3909102
Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L, Hendrix MJ. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res. 2010;70(24):10340-10350. https://doi.org/10.1158/0008-5472.CAN-10-0705
Vartanian A, Gatsina G, Grigorieva I, Solomko E, Dombrovsky V, Baryshnikov A, Stepanova E. The involvement of Notch signaling in melanoma vasculogenic mimicry. Clin Exp Med. 2013;13(3):201-209. https://doi.org/10.1007/s10238-012-0190-9
Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res. 2012;18(10): 2726-2732. https://doi.org/10.1158/1078-0432.CCR-11-3237
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J, Sun T, Wang J, Sun R, Liu Y. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecol Oncol. 2014;133(3):575-583. https://doi.org/10.1016/j.ygyno.2014.02.034
Fernández-Barral A, Orgaz JL, Gomez V, del Peso L, Calzada MJ, Jiménez B. Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism. PLoS One. 2012;7(3):e32989. https://doi.org/10.1371/journal.pone.0032989
Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L, Torre E, Migliore C, Giordano S, Chiarugi P. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med. 2011;51(4):893-904. https://doi.org/10.1016/j.freeradbiomed.2011.05.042
Salinas-Vera YM, Gallardo-Rincón D, García-Vázquez R, Hernández-de la Cruz ON, Marchat LA, González-Barrios JA, Ruíz-García E, Vázquez-Calzada C, Contreras-Sanzón E, Resendiz-Hernández M, et al. HypoxamiRs profiling identify miR-765 as a regulator of the early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells. Front Oncol. 2019;9:381. https://doi.org/10.3389/fonc.2019.00381
Xue H, Gao X, Xu S, Zhang J, Guo X, Yan S, Li T, Guo X, Liu Q, Li G. MicroRNA-Let-7f reduces the vasculogenic mimicry of human glioma cells by regulating periostin-dependent migration. Oncol Rep. 2016;35(3):1771-1777. https://doi.org/10.3892/or.2016.4548
Xu S, Zhang J, Xue H, Guo X, Han X, Li T, Guo X, Gao X, Liu Q, Li G. MicroRNA-584-3p reduces the vasculogenic mimicry of human glioma cells by regulating hypoxia-induced ROCK1 dependent stress fiber formation. Neoplasma. 2017;64(1):13-21. https://doi.org/10.4149/neo_2017_102
Guo J, Cai H, Liu X, Zheng J, Liu Y, Gong W, Chen J, Xi Z, Xue Y. Long non-coding RNA LINC00339 stimulates glioma vasculogenic mimicry formation by regulating the miR-539-5p/TWIST1/MMPs axis. Mol Ther Nucleic Acids. 2018;10:170-186. https://doi.org/10.1016/j.omtn.2017.11.011
Gao Y, Yu H, Liu Y, Zheng J, Ma J, Gong W, Chen J, Zhao L, Tian Y, Xue Y. Long noncoding RNA HOXA-AS2 regulates malignant glioma behaviors and vasculogenic mimicry formation via the MiR-373/EGFR axis. Cell Physiol Biochem. 2018;45(1):131-147. https://doi.org/10.1159/000486253
Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, et al. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Sci Rep. 2016;6:23091. https://doi.org/10.1038/srep23091
Lozano-Romero A, Astudillo-de la Vega H, Terrones-Gurrola MCDR, Marchat LA, Hernández-Sotelo D, Salinas-Vera YM, Ramos-Payan R, Silva-Cázares MB, Nuñez-Olvera SI, Hernández-de la Cruz ON, et al. HOX transcript antisense RNA HOTAIR abrogates vasculogenic mimicry by targeting the angiomiR-204/FAK axis in triple negative breast cancer cells. Noncoding RNA. 2020;6(2):19. https://doi.org/10.3390/ncrna6020019
Liu W, Lv C, Zhang B, Zhou Q, Cao Z. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression. RNA. 2017;23(7):1019-1027. https://doi.org/10.1261/rna.059592.116
Sun Q, Zou X, Zhang T, Shen J, Yin Y, Xiang J. The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer. Gynecol Oncol. 2014;132(3):730-738. https://doi.org/10.1016/j.ygyno.2014.01.047
Guo JQ, Zheng QH, Chen H, Chen L, Xu JB, Chen MY, Lu D, Wang ZH, Tong HF, Lin S. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression. Int J Oncol. 2014;45(3):1065-1072. https://doi.org/10.3892/ijo.2014.2500
Zhang S, Li M, Gu Y, Liu Z, Xu S, Cui Y, Sun B. Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J Exp Clin Cancer Res. 2008;27(1):60. https://doi.org/10.1186/1756-9966-27-60
Li X, Yang Z, Han Z, Wen Y, Ma Z, Wang Y. Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. Oncol Rep. 2018;39(2):827-833. https://doi.org/10.3892/or.2017.6146
Xie HJ, Zhao J, Zhuo-Ma D, Zhan-Dui N, Er-Bu A, Tsering T. Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):3465-3477. https://doi.org/10.1080/21691401.2019.1653900
Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ, Huang Y, Zhao YQ, Jiang H. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer. 2008;18(3):476-486. https://doi.org/10.1111/j.1525-1438.2007.01034.x
Pastorino O, Gentile MT, Mancini A, Del Gaudio N, Di Costanzo A, Bajetto A, Franco P, Altucci L, Florio T, Stoppelli MP, et al. Histone deacetylase inhibitors impair vasculogenic mimicry from glioblastoma cells. Cancers (Basel). 2019;11(6):747. https://doi.org/10.3390/cancers11060747
Maiti A, Qi Q, Peng X, Yan L, Takabe K, Hait NC. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells. Int J Oncol. 2019;55(1):116-130. https://doi.org/10.3892/ijo.2019.4796
Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Cancer Res. 2011;71(18):6073-6083. https://doi.org/10.1158/0008-5472.CAN-11-1704

Закрыть метаданные